BiotechTube
Click Therapeutics

Click Therapeutics

New York, United States· Est.
clicktherapeutics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $104M

Overview

Click Therapeutics is redefining modern medicine by developing patient-centric digital treatments delivered via smartphone and prescribed by physicians. The company leverages a multimodal, platform-based approach that combines scientifically proven therapies with proprietary neuromodulatory mechanisms to drive clinically meaningful outcomes. With an FDA-cleared product for depression and multiple Phase 3 programs in neurology and psychiatry, Click is positioned at the forefront of the rapidly evolving digital therapeutics market. Their innovative Software-Enhanced Drugs™ platform represents a novel approach to enhancing traditional pharmacotherapy through digital interventions.

PsychiatryNeurologyOncology

Technology Platform

Multimodal platform combining scientifically proven therapies with proprietary neuromodulatory mechanisms to create Prescription Digital Therapeutics (PDTs) and Software-Enhanced Drugs™ that integrate software with pharmacotherapy for enhanced clinical outcomes.

Funding History

2
Total raised:$104M
Series C$52M
Series B$52M

Opportunities

The digital therapeutics market is rapidly expanding with FDA creating clearer regulatory pathways.
Click's Software-Enhanced Drugs™ platform enables partnerships with pharmaceutical companies to enhance existing therapies.
Multiple Phase 3 programs nearing completion could lead to several market-ready products within 2-3 years across high-value therapeutic areas.

Risk Factors

Regulatory and reimbursement uncertainty for digital therapeutics, competition from both startups and established pharma companies, adoption challenges with physicians and patients, and technology risks including cybersecurity and platform compatibility issues.

Competitive Landscape

Competitors include Pear Therapeutics (bankrupt), Akili Interactive, Big Health, Woebot Health, Happify Health, and Kaia Health. Click differentiates through prescription-grade treatments with rigorous clinical validation, proprietary neuromodulatory mechanisms, and their innovative Software-Enhanced Drugs™ platform that integrates with traditional pharmacotherapy.

More companies in Digital Health & Biotech SaaS →More companies in United States →